logo
CDC staffers voice frustration over Kennedy's anti-vaccine rhetoric in wake of shooting

CDC staffers voice frustration over Kennedy's anti-vaccine rhetoric in wake of shooting

Yahoo2 days ago
Centers for Disease Control and Prevention staffers are voicing frustration over Health Secretary Robert F. Kennedy Jr.'s past vaccine comments, following Friday's shooting at the agency's headquarters in Atlanta that left one police officer dead.
Although the motive of the suspected shooter — Patrick White, 30, from Kennesaw, Georgia — remains unknown, he told a neighbor that he believed the Covid vaccines had made him sick, a source told NBC News on the condition of anonymity.
Kennedy visited CDC's headquarters earlier Monday, where security led him through campus, pointing out shattered windows across multiple buildings, according to statement from the Department of Health and Human Services. Later, Kennedy met with the widow of the killed police officer.
Employees were instructed to work remotely this week. A virtual only all-staff meeting is scheduled for Tuesday, although it isn't clear if Kennedy will be in attendance.
The shooting took place near the campuses of both the CDC, which includes an on-campus day care center, and Emory University.
For some employees, the shooting highlighted growing hostility toward public health officials, which they feel has been shaped by Kennedy's long history of spreading vaccine misinformation, including the Covid vaccine.
In 2021, Kennedy filed a citizens' petition requesting that the Food and Drug Administration revoke the authorization of the Covid vaccines. The same year, he described the Covid shot as the 'deadliest vaccine ever made.'
Just last week, Kennedy terminated 22 contracts focused on developing mRNA vaccines — the same technology used to develop Pfizer's and Moderna's Covid shots. In an announcement on X, Kennedy claimed 'mRNA technology poses more risks than benefits for these respiratory viruses.'
In an emailed statement, Andrew Nixon, an HHS spokesperson, said Kennedy 'has unequivocally condemned the horrific attack and remains fully committed to ensuring the safety and well-being of CDC employees.'
'This is a time to stand in solidarity with our public health workforce,' Nixon said, 'not a moment for the media to exploit a tragedy for political gain.'
Kennedy has not yet spoken publicly about vaccine misinformation that may have contributed to the shooting.
Numerous studies have shown that the Covid vaccines are safe and effective.
'There's a lot of misinformation, a lot of really dangerous rhetoric that's currently being spread by the current administration, that makes us seem like villains, that makes us seem like our work is setting out to hurt people,' CDC employee Elizabeth Soda said in an interview. 'So it's not at all surprising, right, that people are going to listen to our leaders.'
A 'scapegoat'
Dr. Peter Chin-Hong, infectious disease specialist at the University of California, San Francisco, said the Covid vaccine has become an easy scapegoat — a symbol of all the losses the pandemic inflicted on people, including loss of life, physical and mental health and personal freedoms.
'The vaccine is something you could focus on, instead of a general feeling of loss,' he said.
Even before the shooting at the CDC, there were multiple threats against Dr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases, and other public-health experts. Chin-Hong said he received multiple threatening emails a day at the peak of the pandemic. These days, he gets emails 'full of hate' about once a week. Usually, he reads the first line and then deletes them.
Still, he feels personally unsafe often because he gives public talks about vaccines, he said. As a public health expert, he thinks of that as a duty. The CDC shooting heightened those fears.
'The CDC incident really makes me feel more personally at risk,' he said.
In employee group chats, staffers are also voicing frustration with Kennedy.
'People feel like this is a natural progression when you spend years denigrating science and public health, spread misinformation about vaccines and publicly attack federal workers,' said one CDC employee who was granted anonymity for fear of repercussions.
'Folks, myself included, are pissed off,' the source added.
An employee at the Department of Health and Human Services, which oversees the CDC, said it's not lost on them that Kennedy 'has demonized our work.'
In an email obtained by NBC News, Kennedy told CDC staff on Saturday that he was praying for the entire agency, adding that the shooting was 'deeply unsettling,' especially for those working in Atlanta.
'We want everyone to know, you're not alone,' Kennedy wrote.
This article was originally published on NBCNews.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Yahoo

time20 minutes ago

  • Yahoo

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Conference Call 8:00am ET, Wednesday August 20, 2025 WILMINGTON, Del., Aug. 13, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its second quarter 2025 financial results after the market closes on Tuesday, August 19, 2025 via press release, which will be available on the Company's website at The Company will host a conference call the following morning at 8:00am ET, Wednesday August 20, 2025. The Company requires additional time to compile certain information, including recent developments, into the Form 10-Q necessary for a complete presentation, which it is unable to complete without unreasonable effort. A live webcast of the conference call will be available on the Company's website at Participants that are unable to join the webcast can access the conference call via telephone by dialing domestically +1-800-717-1738 or internationally +1-646-307-1865. About NRx Pharmaceuticals, Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. The Company is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRx has recently filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner's National Priority Voucher Program for the treatment of suicidal depression. The filing is based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and the Government of France, licensed under a data sharing agreement. Notice Regarding Forward-Looking StatementsThe information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. The Company has reported regulatory milestones as they have been achieved but has not predicted the outcome of any future regulatory determination. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, including uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy, and, among other things, liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at Except as may be required by applicable law, the Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise. For further information: Matthew Duffy Brian Korb Co-CEO, Hope Therapeutics, Inc. Managing Partner, astr Partners Chief Business Officer, NRx Pharmaceuticals, Inc. (917) 653-5122 mduffy@ View original content to download multimedia: SOURCE NRx Pharmaceuticals, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

FDA considers revoking Pfizer COVID vaccine for children under 5
FDA considers revoking Pfizer COVID vaccine for children under 5

The Hill

time21 minutes ago

  • The Hill

FDA considers revoking Pfizer COVID vaccine for children under 5

The Food and Drug Administration is considering revoking the authorization of Pfizer's COVID-19 vaccine for healthy children under 5 years old, a move that would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season. Pfizer's three-dose shot for children between 6 months and 5 years old has long been available under an emergency use authorization (EUA). But according to the company, the FDA is weighing ending that authorization. 'We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season,' Pfizer told The Hill. 'It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile,' the company added. Pfizer expects the FDA to approve its vaccine for children ages 5 to 11 with the same limitations as Moderna and Novavax. The FDA in July approved Moderna's shot for children 6 months and older, but only if they have a health condition that puts them at increased risk for severe COVID-19. Novavax has never been approved for children under 12. Pfizer has had full FDA approval for its COVID-19 vaccine for individuals age 12 and older since 2022. It's not unusual for the FDA to revoke emergency authorization on a product if a competitor gains approval for an alternative, and Pfizer has not yet applied for full approval of its COVID-19 vaccine for the youngest age group. All COVID-19 vaccines were initially available only under emergency use authorizations— effectively special permissions given during an emergency if there are no FDA-approved alternatives available. But given the limitation on the Moderna shots, if Pfizer's authorization is pulled, healthy children under 5 years old will have no official options if their parents want to get them vaccinated. 'Parents already were struggling. We had parents, even last year, they had to drive two to three hours to get [COVID] vaccines for their kids. So already, access was an issue. Now it's just going to be abysmal,' said Fatima Khan, co-founder of the group Protect Their Future, which advocates for vaccine access for children. 'You're abandoning children right now … this is something that's so safe and so easy for them to just administer to our kids. Why can we not get it?' Khan said. In a statement to The Hill, the Department of Health and Human Services said it wouldn't comment on potential changes. 'The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023. We do not comment on potential, future regulatory changes. Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation,' HHS spokesman Andrew Nixon said. In May, HHS Secretary Robert F. Kennedy Jr. said that the Centers for Disease Control and Prevention would no longer recommend COVID-19 vaccines for healthy children or pregnant women. The CDC then updated its immunization schedule to reflect that children with no underlying health condition 'may receive' COVID-19 vaccines after consulting with a health care provider. Kennedy has expressed personal antipathy towards the Moderna and Pfizer shots, calling them dangerous and unreliable. HHS also just announced it was pulling back on funding research involving the mRNA technology that was used to develop the vaccines in record time. State health officials said they have been told Moderna is ramping up supplies of its vaccine for the fall and will be able to meet demand if Pfizer's vaccine is no longer available for the youngest children. Providers who already pre-ordered Pfizer shots for the coming season will likely be able to switch to Moderna. But since the Moderna vaccine is only licensed for kids at risk of severe infection, pediatricians will have to offer them 'off label' for healthy kids with no guarantee it will be covered by insurance. 'We're hopeful that the clinical decision making allows them to request the vaccine and get it and have it covered by insurance. But it's just complicated,' said Claire Hannan, executive director of the Association of Immunization Managers, which represents state and local officials. 'The FDA just sort of went outside of the recommendation process in the way that it licensed the Moderna vaccine, and so there's a lot of confusion, and we're just sort of waiting for guidance from CDC on the ordering,' Hannan said. Infectious disease experts have said, and CDC data show, children under age 2 are at risk for severe COVID-19 infection even if they are otherwise healthy. Ayanna Bennett, director of the District of Columbia's Department of Health, said healthy kids should be able to live their best lives. If vaccination will keep them from getting seriously ill, it shouldn't be a question, she said. 'I want kids to not miss two weeks of school. I want kids not to be hospitalized, or in urgent care and miserable. We want them to be able to live their lives when there's no reason why they shouldn't,' Bennett told reporters during a briefing Wednesday. 'If I can prevent something, I should do it, and this is something where we absolutely have prevention available.'

Keller: Are Americans going dry? Why there's some benefits to responsible drinking
Keller: Are Americans going dry? Why there's some benefits to responsible drinking

CBS News

time22 minutes ago

  • CBS News

Keller: Are Americans going dry? Why there's some benefits to responsible drinking

A new Gallup poll finds the percent of American adults who say they drink alcohol has dropped its lowest point in nearly a century. But while health issues are driving some of the decline, we spoke with two experts who say there are risks to abstaining as well. The 54% who said they drink even sparingly is down from the record highs in the 70s of 50 years ago. When drinking gets out of control, it's a given that trouble can follow. And the Gallup poll shows the decline in drinking is tied to mounting concerns over its impact on health, especially among young adults. But there's another, more positive side to responsible drinking - the social and cultural benefits of bonding with others "where everybody knows your name." "It just makes people feel part of something, and when that gets lost people feel a little isolated," said Maureen Nuccitelli of Watertown, a former bartender turned wellness coach. She said modestly-relaxed inhibitions and the company of friendly others can be a key part of a well-balanced lifestyle. "Sharing a few laughs really helps people lower their stress response and release some of those feelgood hormones and chemicals." The poll suggests at least some young adults may be eschewing alcohol in favor of marijuana. But British drinking culture expert Jane Peyton, founder of the online School of Booze, said, "If you're smoking a joint or if you're eating a gummy, you don't cheers anybody first before you do it." Peyton said it's no surprise that socializing via phone or social media and using marijuana don't provide the bonding experience that responsible alcohol use can. "We need somewhere that we can go as a community or go in a group, be with other people, and a bar or a pub is a perfect place to do that," said Peyton. In fact, said Peyton, in pub culture, the alcohol is beside the point. "If you just drink it moderately and enjoy it, you get the best out of it. So the thing to do with alcohol is get the best out of alcohol and don't let it get the best out of you." Will drinking fade away like cigarette smoking did, now practiced by less than 12% of the population? That's hard to believe, given that it's been a habit for more than 13,000 years and remains the second-most popular drug in the world, trailing only caffeine. It was telling that churches, schools, even public parks were shut down when COVID hit, but not the liquor stores. The question brings to mind a famous polka song that may offer an answer: "In heaven there is no beer/That's why we drink it here."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store